Guardion Health Sciences IncNASDAQ:GHSI
- LAST PRICE7.9000
- TODAY'S CHANGE (%)-0.2499 (-3.0663%)
- Bid / Lots7.5900/ 2
- Ask / Lots8.7300/ 7
- Open / Previous Close7.9400 / 8.1499
- Day Range
- 52 Week Range
- Volume3,146
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GHSI |
|---|---|---|
| 11:44 ET | 900 | 7.92 |
| 02:33 ET | 100 | 8.1899 |
| 03:32 ET | 107 | 8.03 |
| 03:38 ET | 200 | 8.095 |
| 03:59 ET | 1446 | 7.9 |
Mar 29, 2024
*DJ Guardion Health Sciences 2023 Rev $12.2M >GHSI, from 6:15AM ET on Friday Mar 29, 2024 by Dow Jones
6:15AM ET on Friday Mar 29, 2024 by Dow JonesGuardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023, from 6:15AM ET on Friday Mar 29, 2024 by Dow Jones
6:15AM ET on Friday Mar 29, 2024 by Dow JonesGuardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023, from 6:15AM ET on Friday Mar 29, 2024 by Dow Jones
6:15AM ET on Friday Mar 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Guardion Health Sciences Inc | 10.5M | 63.6x | --- |
Sonoma Pharmaceuticals Inc | 2.5M | -0.2x | --- |
GSRX Industries Inc | 16.4K | 0.0x | --- |
CV Sciences Inc | 6.5M | 1.8x | -25.43% |
China Pharma Holdings Inc | 4.8M | -0.3x | --- |
United-Guardian Inc | 38.5M | 14.7x | -9.92% |
Company Information
Guardion Health Sciences, Inc. is a clinical nutrition company. The Company offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The Company, through Activ Nutritional, LLC (Activ), owns the Viactiv line of supplements for bone health and other applications. The Viactiv line of supplements contains several flavored nutritional supplement products, but the milk chocolate and caramel flavored calcium chews constitute the main product category. It also sells Lumega-Z, its medical food product that has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. The Company's GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress.
Contact Information
- Headquarters
- 2925 Richmond Avenue, Suite 1200HOUSTON, TX, United States 77098
- Phone
- ---
- Fax
- 858-630-5543
Executives
- Independent Non-Executive Chairman of the Board, Non-Employee Corporate Secretary
- Robert Weingarten
- President, Chief Executive Officer
- Janet Hall
- Chief Accounting Officer
- Katie Cox
- Chief Commercial Officer
- Craig Sheehan
- Independent Director
- Donald Gagliano
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.5M |
|---|---|
Revenue (TTM) | $12.2M |
Shares Outstanding | 1.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.89 |
EPS | $0.12 |
Book Value | $6.39 |
P/E Ratio | 63.6x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | 59.0x |
Operating Margin | -34.34% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
